ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Sanofi to acquire Kymab for up to $1.45bn pharmatimes
January 12, 2021Sanofi will acquire Cambridge, UK-based biopharmaceutical company Kymab in a potential $1.45bn deal, which will see the French pharma add Kymab’s monoclonal antibody (mAB) KY1005 to its pipeline. -
Kymab wins UK court case against Regeneron’s patent claims europeanpharmaceuticalreview
June 30, 2020The UK Supreme Court has ruled that Regeneron’s patent claim regarding genetically modified mice against Kymab are invalid. -
Kymab announces Merck exec Simon Sturge as new CEO pharmafile
April 11, 2019Kymab announces Merck exec Simon Sturge as new CEO. -
Kymab, Roche Partner to Evaluate KY1044
contractpharma
July 03, 2018Kymab Group Ltd?has entered a clinical trial agreement with?Roche. Under the agreement, Roche will provide its PD-L1 blocking antibody atezolizumab for use in combination in Kymab’s upcoming Phase I-II clinical studies combining
Pharma Sources Insight January 2025
